These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 18410891)

  • 1. The clinical outcome of Hurler syndrome after stem cell transplantation.
    Aldenhoven M; Boelens JJ; de Koning TJ
    Biol Blood Marrow Transplant; 2008 May; 14(5):485-98. PubMed ID: 18410891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental outcome in five children with Hurler syndrome after stem cell transplantation: a pilot study.
    Lücke T; Das AM; Hartmann H; Sykora KW; Donnerstag F; Schmid-Ott G; Grigull L
    Dev Med Child Neurol; 2007 Sep; 49(9):693-6. PubMed ID: 17718826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dried blood spot analysis: an easy and reliable tool to monitor the biochemical effect of hematopoietic stem cell transplantation in hurler syndrome patients.
    Aldenhoven M; de Koning TJ; Verheijen FW; Prinsen BH; Wijburg FA; van der Ploeg AT; de Sain-van der Velden MG; Boelens J
    Biol Blood Marrow Transplant; 2010 May; 16(5):701-4. PubMed ID: 20096360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variable disease progression after successful stem cell transplantation: prospective follow-up investigations in eight patients with Hurler syndrome.
    Grigull L; Sykora KW; Tenger A; Bertram H; Meyer-Marcotty M; Hartmann H; Bültmann E; Beilken A; Zivicnjak M; Mynarek M; Osthaus AW; Schilke R; Kollewe K; Lücke T
    Pediatr Transplant; 2011 Dec; 15(8):861-9. PubMed ID: 22112002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factor analysis of outcomes after unrelated cord blood transplantation in patients with hurler syndrome.
    Boelens JJ; Rocha V; Aldenhoven M; Wynn R; O'Meara A; Michel G; Ionescu I; Parikh S; Prasad VK; Szabolcs P; Escolar M; Gluckman E; Cavazzana-Calvo M; Kurtzberg J;
    Biol Blood Marrow Transplant; 2009 May; 15(5):618-25. PubMed ID: 19361754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Umbilical cord blood from an unrelated donor as source for stem cell transplantations in inborn errors of metabolism].
    Aldenhoven M; de Koning TJ; Wulffraat NM; Boelens JJ
    Ned Tijdschr Geneeskd; 2008 Aug; 152(31):1719-24. PubMed ID: 18727602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychological development in children with Hurler syndrome following hematopoietic stem cell transplantation.
    Peters C; Shapiro EG; Krivit W
    Pediatr Transplant; 1998 Nov; 2(4):250-3. PubMed ID: 10084724
    [No Abstract]   [Full Text] [Related]  

  • 8. Pre-stem cell transplantation enzyme replacement therapy in Hurler syndrome does not lead to significant antibody formation or delayed recovery of the endogenous enzyme post-transplant: a case report.
    Soni S; Hente M; Breslin N; Hersh J; Whitley C; Cheerva A; Bertolone S
    Pediatr Transplant; 2007 Aug; 11(5):563-7. PubMed ID: 17631030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
    Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A
    J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome in six children with mucopolysaccharidosis type IH, Hurler syndrome, after haematopoietic stem cell transplantation (HSCT).
    Malm G; Gustafsson B; Berglund G; Lindström M; Naess K; Borgström B; von Döbeln U; Ringdén O
    Acta Paediatr; 2008 Aug; 97(8):1108-12. PubMed ID: 18452566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic stem cell transplantation for genetic disorders.
    Soni S
    J Ky Med Assoc; 2007 Jan; 105(1):12-6. PubMed ID: 17310873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The syndrome of inappropriate secretion of antidiuretic hormone associated with SCT: clinical differences following SCT using cord blood and BM/peripheral blood.
    Suzuki Y; Kobayashi R; Iguchi A; Sato T; Kaneda M; Kobayashi K; Ariga T
    Bone Marrow Transplant; 2008 Dec; 42(11):743-8. PubMed ID: 18711342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome.
    Tolar J; Grewal SS; Bjoraker KJ; Whitley CB; Shapiro EG; Charnas L; Orchard PJ
    Bone Marrow Transplant; 2008 Mar; 41(6):531-5. PubMed ID: 18037941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucopolysaccharidosis I: management and treatment guidelines.
    Muenzer J; Wraith JE; Clarke LA;
    Pediatrics; 2009 Jan; 123(1):19-29. PubMed ID: 19117856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haematopoietic stem cell transplantation for autoimmune disease: limits and future potential.
    Brenner MK
    Best Pract Res Clin Haematol; 2004 Jun; 17(2):359-74. PubMed ID: 15302346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic graft-versus-host disease after allogeneic stem cell transplantation: challenges in prevention, science, and supportive care.
    Joseph RW; Couriel DR; Komanduri KV
    J Support Oncol; 2008; 6(8):361-72. PubMed ID: 19149321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Musculoskeletal manifestations in mucopolysaccharidosis type I (Hurler syndrome) following hematopoietic stem cell transplantation.
    Schmidt M; Breyer S; Löbel U; Yarar S; Stücker R; Ullrich K; Müller I; Muschol N
    Orphanet J Rare Dis; 2016 Jul; 11(1):93. PubMed ID: 27392569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.
    Wahlin A; Billström R; Björ O; Ahlgren T; Hedenus M; Höglund M; Lindmark A; Markevärn B; Nilsson B; Sallerfors B; Brune M
    Eur J Haematol; 2009 Aug; 83(2):99-107. PubMed ID: 19385987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute complications of stem cell transplant.
    Rimkus C
    Semin Oncol Nurs; 2009 May; 25(2):129-38. PubMed ID: 19411016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with early relapse of primary hemophagocytic syndromes or with persistent CNS involvement may benefit from immediate hematopoietic stem cell transplantation.
    Sparber-Sauer M; Hönig M; Schulz AS; zur Stadt U; Schütz C; Debatin KM; Friedrich W
    Bone Marrow Transplant; 2009 Sep; 44(6):333-8. PubMed ID: 19252534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.